Aug 3 (Reuters) - Eli Lilly and Co:
* ELI LILLY SAYS INTENDS TO MAKE BEBTELOVIMAB COMMERCIALLY AVAILABLE FOR PURCHASE BY U.S. STATES/TERRITORIES, THROUGH SOLE DISTRIBUTOR FROM AUG. 15 Source text Further company coverage:
Aug 3 (Reuters) - Eli Lilly and Co:
* ELI LILLY SAYS INTENDS TO MAKE BEBTELOVIMAB COMMERCIALLY AVAILABLE FOR PURCHASE BY U.S. STATES/TERRITORIES, THROUGH SOLE DISTRIBUTOR FROM AUG. 15 Source text Further company coverage:
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
724.9 USD | -1.00% | -2.83% | 660B | ||